Tag Archives: BIVVV

After Completion Of Spinoff From Biogen(BIIB), Bioverativ(BIVV) Aims To Stop The Bleeding

By |
5 Comments
bioverativ logo

On February 1, Biogen(BIIB) completed the spinoff of its Hemophilia business, Bioverativ(BIVV).  Biogen shareholders woke up on February 2 to find one share of Bioverativ in their portfolio for every two shares of Biogen that they had owned. Biogen has had a tumultuous year, with the departure of its longtime CEO George Scangos in January amidst stalling sales. Xconomy’s… Read More »

Biogen(BIIB) Spinoff Bioverativ(BIVV) Begins Trading On A When Issued Basis

By |
7 Comments

Biogen(BIIB) enters the final days before its spinoff of Bioverativ(BIVV), its global hemophilia business, as the new company begins when issued trading under the ticker BIVV. After the close of business on February 1, Biogen shareholders as of January 17 will receive one share of Bioverativ for every two shares they own.  The distribution is expected to be… Read More »